GlassScriptPhysician profile
Chung Wei Hsu
NPI 1174600381
$1,340.96
in general payments reported to CMS, 2019-2025
20 companies · $220 in 2025
The $220 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $302 · 2020: $58.25 · 2021: $67.37 · 2022: $31.50 · 2023: $363 · 2024: $300 · 2025: $220.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $844 · Entertainment: $37.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $844.40 |
| Entertainment | $37.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $223.05 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Pfizer INC. | $191.80 | 2019-2025 | |
| Lilly USA, LLC | $110.00 | 2020-2025 | Zepbound, Mounjaro, Jardiance |
| Novo Nordisk INC | $102.85 | 2021-2024 | Rybelsus, Ozempic, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $96.69 | 2023-2025 | Jardiance |
| Amgen INC. | $96.05 | 2019-2025 | Evenity |
| Exact Sciences Corporation | $72.40 | 2024-2025 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $71.05 | 2019-2024 | Arexvy, Trelegy Ellipta, Shingrix |
| Amarin Pharma, INC. | $70.50 | 2019-2021 | |
| Gilead Sciences, INC. | $52.38 | 2019-2020 | |
| Boston Scientific Corporation | $49.43 | 2023 | Wavewriter Alpha Prime 16 |
| Optos, INC. | $37.85 | 2023-2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Dexcom, INC. | $37.33 | 2023 | Dexcom G6 Transmitter |
| Echosens North America, INC. | $25.72 | 2023 | Fibroscan |
| Bayer Healthcare Pharmaceuticals INC. | $21.09 | 2024 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Itamar Medical INC | $20.92 | 2023 | Watchpatone |
| Genentech USA, INC. | $16.98 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $15.38 | 2023 | Kristalose |
| Abbott Laboratories | $15.06 | 2023 | Freestyle Libre 3 |
| Merck Sharp & Dohme LLC | $14.43 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chung Wei Hsu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.